Chemosensing in nature relies on biomolecular switches, biomolecules that undergo binding-induced changes in conformation or oligomerization to transduce chemical information into specific biochemical outputs. Motivated by the impressive performance of these natural 'biosensors,' which support continuous, real-time detection in highly complex environments, significant efforts have gone into the adaptation of such switches into artificial chemical sensors. Ongoing advances in the fields of protein and nucleic acid engineering (e.g. computational protein design, directed evolution, selection strategies and labeling chemistries) have greatly enhanced our ability to design new structure-switching sensors. Coupled with the development of advanced optical readout mechanisms, including genetically encoded fluorophores, and electrochemical readouts supporting detection directly in highly complex sample matrices, switchbased sensors have already seen deployment in applications ranging from real time, in vivo imaging to the continuous monitoring of drugs in blood serum. 
Introduction
The impressive specificity, affinity, and versatility of biomolecular recognition have motivated decades of research on the development of sensors based on this effect. A significant hurdle in the development of these technologies, however, is that most biomolecules do not respond in any easily measurable way upon binding their target ligands. Antibodies, for example, do not change their shape or emit electrons or photons upon binding their target antigens. Owing to this, existing bio-analytical approaches, including ELISAs, western blots and PCR, are typically multistep, washing-intensive and reagentintensive processes. As such, these approaches are ill suited for use outside the laboratory, and impossible to deploy in real-time or in situ applications. In order to overcome this limitation, a number of sensors have been developed that detect binding in real time by monitoring a change in mass, charge or optical properties that occurs when the target binds a biomolecule-coated surface (e.g. surface plasmon resonance, field-effect transistor, quartz crystal microbalance and microcantilevers). Unfortunately, however, these approaches also suffer from a serious drawback: because they detect adsorption to the sensor head rather than a specific binding per se, they cannot distinguish between the binding of the correct, authentic target and the non-specific binding of contaminants. They thus fail when challenged with realistically complex samples, such as blood serum [1] . In short, the goal of reagentless, real-time sensors that can be deployed directly in complex samples remains largely unmet [1] .
Long ago, Nature solved the problem of real-time molecular sensing in complex environments; lessons learned from these natural, protein-based and nucleic acid-based 'biosensors' could therefore assist in the development of improved sensing technologies. Tellingly, these naturally occurring sensors do not detect their targets via bindinginduced changes in adsorbed mass or charge. They instead respond to their targets by undergoing specific, bindinginduced changes in conformation or oligomerization state [2] . These switching events, in turn, trigger specific output signals, such as the opening of an ion channel or the activation of an enzyme. Inspired by the speed, specificity and versatility of these naturally occurring sensors, significant efforts have gone into the fabrication of artificial biosensors based on this principle. Here we review recent efforts to develop such structure-switching sensors.
The many advantages of biomolecular switches
As noted above, biomolecular switches are proteins or nucleic acids that reversibly shift between two or more conformations (or conformational ensembles) in response to the binding of a specific target ligand. Several attributes render such switches well suited for adaptation into artificial sensors. First, binding-specific conformational changes offer a robust means of transducing a binding event into an output signal that is not easily mimicked by non-specific effects. That is, because structure switching is induced by the formation of many weak, noncovalent bonds (e.g. hydrogen bonding, hydrophobic effect, and van der Waals forces), it is generally specific to a given ligand-biomolecule interface and thus largely insensitive to the presence of other molecules present in highly complex environments (Figure 1 ). Second, switching, and thus signal transduction, is rapid, reversible, and reagent-free, allowing these nanoscale switches to support continuous, real-time detection even inside of living cells (Figure 1a) . Third, biomolecular switches are versatile; as discussed at length below, switching can be coupled to a number of specific optical, electrochemical and biochemical outputs ( Figure 2 ) and can be engineered into a wide range of biomolecules spanning a nearly equally wide range of binding specificities ( Figure 3) . Finally, the conformational equilibria of biomolecular switches are related to both target concentration and to the switch's underlying thermodynamics. This renders switch-based sensors quantitative and provides a means by which their dynamic ranges can be rationally optimized without altering their binding specificity (Figure 4 ). Given these attributes, it is perhaps not surprising that a large number of structure-switching biosensors have been reported in recent years. Here we review the mechanisms by which biomolecular switches have been coupled to optical, electronic and biochemical 'readouts,' current approaches to the design of structure-switching sensors and, finally, methods by which the thermodynamics of such switches can be modified in order to optimize their signaling.
Coupling switching to a readily measurable output signal
The development of structure-switching sensors requires that the switch's conformational state be linked to a readily detectable output. To date, structure-switching sensors have been described that respond to their targets via conformation-linked changes in fluorescence emission (for optical detection), electron transfer (for electrochemical detection) or biochemical (catalytic or binding) activity.
The most widely employed method for linking structure switching to a specific output has been to use conformation-linked fluorescence quenching. This has been achieved via: a change in the microenvironment around a single, structure-sensitive fluorophore ( Figure 2a) ; a distance-dependent change in the Forster Resonance Energy Transfer (FRET) between a donor/acceptor fluorophore pair ( Figure 2b) ; or a distance-dependent change in excimer formation or electron transfer based fluorescence quenching (Figure 2b ). Fluorescent reporters utilized in such applications include a wide range of commercially available organic dyes as well as a number of brighter, if more complex, structures including dyelabeled microspheres, fluorescent dendrimers and polymers, narrow-bandwidth semiconductor nanocrystals (quantum dots), and, for in vivo applications, fluorescent proteins and fluorophore-binding polypeptides and nucleic acids (reviewed in [5, 6] ).
Hellinga and coworkers have published an exhaustive study of the design of sensors employing single, environmentally sensitive fluorophores. They constructed more Real-time molecular detection in complex samples using structure-switching sensors. (a) Tsien and coworkers have developed a genetically encoded, calcium-sensitive switch by fusing calmodulin (a calcium binding protein), M13 (a calmodulin binding polypeptide) and two fluorescent protein reporter domains. As shown (lower left), they have employed this sensor to monitor calcium ion dynamics at the plasma membrane of hippocampal neurons following a simulation with 100 mM histamine [3] . (b) We have demonstrated an electrochemical, aptamer-based switch that folds upon cocaine binding. Affixed via one terminus to an electrode and modified at the other with a redox-active methylene blue molecule, the binding-induced folding of this aptamer leads to a large increase in current, supporting the real-time detection of micromolar cocaine in blood serum as it flows through the depicted, submicroliter micro-fluidic device [4 than 320 such sensors using 8 different fluorophores and 11 different proteins in the bacterial perisplasmic binding protein (bPBP) superfamily (Figure 2a ) [7] . Using the known or modeled structures of the bound and unbound states of their proteins, the authors placed reporting fluorophores in positions thought likely to undergo significant environmental changes upon the binding-induced conformational change. By doing so they succeeded in generating efficient fluorescent sensors from all 11 of the proteins they investigated in this superfamily. A caveat of this approach, however, is that even when the structures of the two conformations of the switch are known (or can be accurately modeled), it is difficult to predict the detailed and complex interactions that occur between the fluorophore and the protein surface. Indeed, only 4% of their 320 variant sensors produced a substantive change in absolute fluorescence upon target binding [7] .
Despite the inherently greater complexity associated with their fabrication, sensors employing dual optical reporters ( Figure 2b ) offer important advantages over single-fluorophore sensors and have thus seen more widespread application [5] . For example, FRET-based sensors are ideally suited for in vivo imaging; by measuring the ratio of donor-to-acceptor emission, FRET automatically corrects for variation in the concentration of the sensor within a cell [6] . Likewise, two-reporter fluorophore/ quencher constructs often produce very 'dark' non-signaling conformations. Because of this, binding can produce very large increases in fluorescence, rendering such sensors particularly sensitive [8] .
While the 1/r 6 donor-to-acceptor distance dependence of FRET supports robust signaling in many applications, the characteristic Fö rster radii (distance at which the energy transfer efficiency reaches 50%) of visible-light FRET pairs are large relative to the 1-2 nm conformational changes produced by many biomolecular switches. Recent years have thus seen the development of fluorescent readouts that rely instead on electron transfer based quenching [9] , which falls off exponentially with distance, or excimer (excited state dimer) formation, which is still more strongly distance-dependent [10, 11] . The strong distance dependencies of these mechanisms ensure that conformational changes of even a few tenths of a nanometer can produce large, multifold changes in fluorescence intensity. To date these readout mechanisms have been employed to monitor a number of binding-induced conformational changes, including the folding of short polypeptide epitopes upon binding their target antibodies [11] [12] [13] and the folding of DNA aptamers upon binding to their target ligands [10] .
While optical readout mechanisms have proven well suited for applications such as in vivo imaging (Figure 1a ), fluorescent and strongly absorbing substances are common in clinical and environmental samples, reducing the utility of optical approaches in many applications. Electroactive contaminants, in contrast, are rare and thus electrochemical methods for monitoring biomolecular switching perform well even in highly heterogeneous samples (Figure 1b) . Switch-based electrochemical sensors are typically engineered by attaching an electroactive reporter (e.g. ferrocene or methylene blue) to one position on the biomolecule that, in turn, is fixed onto an electrode surface via a second, distal position. Binding-induced conformational changes will thus alter the redox current produced by the reporter, leading to a readily measurable electrochemical signal (Figure 2c ) [14] . To date, such structure-switching electrochemical sensors have been fabricated from a range of nucleic acid-based [15] [16] [17] , polypeptide-based [18] and protein-based switches [19] . Sensors employing nucleic acid switches have proven particularly amenable to this approach, with sensors directed against specific nucleic acid sequences [20] , proteins (e.g. thrombin [21] and PDGF [22] ) and small-molecule targets (e.g. cocaine Engineering structure-switching biosensors Vallé e-Bé lisle and Plaxco 521 Figure 4 Tuning the dynamic range of a switch by optimizing its switching equilibrium, K S . (a) Switching is well described by a population-shift model in which a pre-existing equilibrium between a non-binding 'off' state and a binding-competent 'on' state is pushed toward the latter by target binding [49 ] . (b)-(c) Increasing the stability of the 'off' state (reducing K S ) proportionally decreases the switch's affinity for its target (higher K obs D ), providing a means of rationally 'tuning' the dynamic range of a switch without altering its binding specificity. The lowest possible detection limits are generally achieved with equilibrium constants near unity (K S % 1) [49 ] ; under these conditions, a large population of switches are poised to respond to the target (leading to high sensor gain) without a concomitantly grave reduction in affinity. Strategies for the design of switches from a biomolecule that binds the desired molecular target. (a) If a naturally occurring switch exists that binds the target of interest it can readily be converted into a sensor. Alternatively, computational redesign or in vitro selections can be used to expand the range of targets recognized by such a switch, allowing the generation of sensors for novel targets. In a complementary set of approaches, a non-switching biomolecule that binds the target of interest can be re-engineered to undergo binding-induced switching via: (b) linking the recognition biomolecule to a naturally occurring effector; (c) stabilizing an alternative, non-binding conformation of the recognition biomolecule; or, (d) destabilizing the recognition biomolecule so that it only folds upon target binding.
[23]) having been described to date. In every case, these electrochemical sensors are rapid (responding in seconds to minutes), sensitive (detecting subpicomolar to micromolar concentrations), and selective enough to support detection in complex samples (e.g. blood serum, Figure 1b) . They are also operationally convenient: they are supported on micron-scale electrodes [4 ] , enabling parallelizability, are low cost, and because the switch is covalently attached to the electrode, are typically reusable [15] [16] [17] .
In addition to optical and electrochemical outputs, other strategies have been described in which structure switching activates or inhibits the function of a second, reporting domain to produce a biochemical output. Advantages offered by these readouts include the opportunity to amplify the output signal via catalysis and the ability to encode such sensors genetically for in vivo sensing. An early example of such a sensor was created by Ghadiri and coworkers, who covalently linked a protease to its inhibitor via a single-stranded DNA linker. Hybridization of the DNA with its complement rigidifies this linker, removing the inhibitor from the enzyme and allowing it to proteolyze -and thus activate -a fluorescent reporter (Figure 2d) [24]. A second approach, inspired by protein-fragment complementation assays (a strategy used to monitor protein-protein interactions in vivo [25] ), utilizes switching to assemble two fragments of a catalytic signaling domain (Figure 2e ). Examples include switches designed to activate the enzymes aequorin [26 ] and luciferase [27] , producing bioluminescence in response to target binding. Finally, switch-controlled enzymes and ribozymes have been constructed in which switching induces or releases mechanical tension in the reporting domain, thus modulating its activity (Figure 2f ) ( [28] , see also [29, 30] for recent reviews). Examples include sensors based on the switch-induced distortion of enzymes (e.g. b-galactosidase [28, 29] ), ribozymes (e.g. the hammerhead ribozyme [31] ), DNAzymes (e.g. a peroxidase-mimicking DNAzyme [32] ) and fluorophore-binding aptamers (e.g. the binding of malachite green dye [33] ).
Sensors based on naturally occurring switches
Not surprisingly, the first reported examples of structureswitching sensors employed naturally occurring switches in the detection of their natural binding partners. Specifically, in the late 1990s Hellinga and coworkers converted maltose binding protein, a member of the Escherichia coli superfamily of periplasmic binding proteins, into a fluorescent sensor for maltose [34] . Conveniently, members of this superfamily undergo large hinge-bending motion when their target binds to a cleft separating the protein's two domains. In the intervening years, numerous other members of this superfamily have been employed in sensing, with targets including maltose, glucose, ribose, arabinose, glutamine, glutamate, histidine, Fe(III), Ni(II), phosphate, sulfate and, finally, dipeptides (reviewed in [35, 36] ). Several of these, including the maltose [37] , glucose [38] and glutamate [39, 40 ] sensors, have been adapted into expressible, genetically encoded sensors using fluorescent protein reporters and used to map target concentrations in vivo. The glucose and maltose binding proteins have also been adapted into electrochemical sensors, supporting the electronic monitoring of glucose in blood serum and maltose in beer [19] . Further highlighting the versatility of switch-based readout mechanisms, maltose binding protein has also been coupled to an enzymatic readout via linkage to a b-galactosidase catalytic domain [28] .
Designing switches for the detection of novel targets
Naturally occurring switches can detect only a limited number of binding partners (Figure 3a) . Fortunately, however, two approaches have been developed by which biomolecular switches can be engineered to respond to novel targets. The first of these approaches starts with an existing, naturally occurring switch and redesigns or reselects its binding site to support recognition of the desired new target. The second starts with an existing binding site (either naturally occurring or the product of in vitro selection) and re-engineers the host biomolecule so that it undergoes switching upon target binding.
Altering the specificity of an existing switch
Using the above-described maltose binding protein as a scaffold, Hellinga and coworkers pioneered the use of computational protein engineering to convert existing, naturally occurring switches into sensors for novel targets. Using this approach they have reported fluorescent sensors for a number of small molecule and inorganic ion targets, including Zn(II), trinitrotoluene (TNT), lactate, serotonin and pinacolyl methyl phosphonic acid (PMPA) (reviewed in [35] ). Of note, however, recent characterization of the binding properties of the switches directed against serotonin, lactate, TNT and PMPA and related crystallographic studies of the serotonin sensor suggest that none of these redesigned sensors bind their ligands as anticipated; the computational redesign of binding sites appears to be far from a solved problem [41 ] . Nevertheless, ongoing advances in this field [42] , including the recent successful design of non-natural enzymes [43] , suggest that this approach may soon reach fruition. In the meantime, directed evolution provides an alternative means of generating new binding specificities. As an example, Ostermeier and coworkers have created a switch from maltose binding protein that reports via b-lactamase activity (see Figure 2e) , allowing them to use an ampicillin-survival assay to screen for sucrose-responsive switches from a library of 4 Â 10 6 random switch variants [44] . Strategies for the in vitro selection of structureswitching aptamers have also been described. Nutiu and Li, for example, demonstrated a method by which specific, structure-switching aptamers can be eluted from a column when ligand binding induces a conformational change that disrupts the hybridization of a portion of their sequence to a complementary sequence fixed to the column [45] .
Engineering switching into an arbitrary biomolecule
Despite some successes, re-engineering a biomolecular switch so that it binds new ligands remains a complex and time-consuming challenge. Fortunately, several strategies have been reported by which arbitrary biomolecules can be redesigned to undergo switching upon target binding (Figure 3) , an approach that allows bioengineers to exploit the binding specificities of biomolecules that lack structure-switching activity. These strategies include: fusion of the recognition biomolecule to an effector that binds only its target-bound form; engineering an alternative, non-binding conformation of the recognition biomolecule in equilibrium with its target-binding conformation or destabilizing the recognition biomolecule, thus creating a biomolecule that folds only upon binding its target ligand. As described below, each of these approaches has seen notable recent successes.
Many biomolecules bind a second, 'effector' biomolecule after binding their target ligand (Figure 3b, left) . An example is the protein calmodulin, which, in its calcium-bound state, binds to many other proteins and polypeptides [46] . Tsien and coworkers have employed this effect to design a genetically encoded calcium sensor comprising four components: calmodulin, a polypeptide named M13 that binds the calcium-bound form of calmodulin, and two fluorescent protein FRET reporters (Figure 1a ) [3] . Similar sensors have more recently been reported for the in vivo detection of Zn 2+ [47] and GTPase activation (i.e. when guanosine triphosphate is bound to a specific GTPase) [48] , further speaking to the utility of this approach.
Switching occurs when the ground state (most stable conformation) of a biomolecule differs from the conformation that binds its target ligand [49 ] . Binding stabilizes the latter conformation, causing the population to shift to this state. A second approach by which nonswitching biomolecules can be re-engineered to undergo a large-scale conformational change upon target binding is thus to stabilize an alternative conformation of the biomolecule that does not bind the target. Molecular beacons, which were introduced by Kramer and coworkers in the late 1990s, provide an illustrative example [50] . Comprising a reporter-modified DNA strand, molecular beacons switch between a non-binding stem-loop conformation and a binding-competent linear conformation. Hybridization with a complementary target stabilizes the latter state, leading to a large increase in net fluorescence (for fluorophore/quencher-modified molecular beacons [51] ), or redox current (for electrochemical, E-DNA sensors [15, 20] ). Similar strategies have been used to create structure-switching aptamers, which in turn have been adapted to optical [52, 53] and electrochemical [16, 17] sensors for the detection of a wide range of analytes. We note, however, that most of the reported examples of this approach to switch design involve nucleic acid-based switches. This is because the rational design of an alternative fold is far easier for nucleic acids than for proteins [42] : the simple complementarity of base pairing renders the design of alternate nucleic acid conformations quite straightforward [54] . Nevertheless, Loh and coworkers have demonstrated a strategy for the design of novel protein-based switches [55 ] . Their method, which they term 'alternate frame folding,' involves duplication of a portion of a protein's sequence, which introduces a second, low-energy 'circularly permuted' conformation. The introduction of mutations that disrupt target binding for the lower energy of these two conformations thus links binding to a large shift in the conformational population of the switch. Using this approach, they have converted the protein calbindin D 9k into a fluorescent sensor that responds robustly to calcium [55 ] .
Despite the success of Loh's alternative frame folding approach, the design of stable, alternative conformations remains a challenge for protein-based sensors. Fortunately, a still easier strategy exists by which proteins and nucleic acids can be re-engineered to undergo binding-induced conformational changes. This strategy relies upon the principle that the folding of simple, singledomain biomolecules is a highly cooperative, largely two-state process (see, e.g. [56] ). By introducing sufficiently destabilizing mutations (typically remote from the target binding site so as to ensure that specificity is retained) it is possible to push the folding equilibrium constant arbitrarily far toward the unfolded state (Figure 3d ). Such an unfolded biomolecule still samples its native, binding-competent conformation. In the presence of its target, the unfolded-folded equilibrium thus shifts back toward the native configuration. This transduction mechanism, which is extensively employed in nature [57, 58] , has seen use in the design of a number of artificial protein-based [59] and nucleic acid-based [60] sensors to date, in both optical (reviewed in [13] ) and electrochemical formats (e.g. Figure 1b ) [17, 18] .
Optimizing performance of biomolecular switches
Biomolecular switching typically occurs via a populationshift mechanism in which the equilibrium between a nonbinding state and a binding-competent state is shifted when the target binds the latter (Figure 4a ) [49 ] . The switching equilibrium constant, K S , thus significantly impacts sensor performance. Specifically, K S must favor the non-binding state (K S < 1) in order to obtain a large population of switches that are poised to respond upon the introduction of target. Conversely, binding is coupled to the switching equilibrium (Figure 4a) , and thus K S also affects the switch's affinity for its ligand [61] ; as K S becomes smaller, binding must overcome a more unfavorable switching equilibrium and thus affinity is reduced. For these reasons, care must be taken to tune K S so that it matches the specific application at hand. For example, K S can be tuned to optimize the detection limit of the sensor (i.e. for detecting the lowest possible concentration of target) or it can be altered so as to shift the dynamic range of a sensor so that its optimal sensitivity (change in signal/change in target concentration) is achieved over the relevant range of target concentrations.
As an exploration of the 'population-shift' model of switching, and to highlight the importance of K S in defining sensor performance, we recently designed a set of six switches differing only in K S (Figure 4b ) [49 ] . Consistent with the population-shift model, the observed affinities of this set of related switches are inversely proportional to K S as it is varied over four orders of magnitude (Figure 4c ). The lowest detection limits are achieved at a K S of approximately unity (K S % 1), conditions under which the sensor achieves reasonable gain (50% of the maximal possible signal change is captured) with only a twofold reduction in affinity. The precise value of K S at which the lowest possible detection limit is achieved, however, will depend on the gain of the sensor (the signal change upon target binding) and on whether the detection limit is defined by its absolute signal change or the relative change in signal relative to any background.
The link between switching thermodynamics and switch affinity (Figure 4b ,c) provides a convenient route by which the, typically two orders of magnitude, dynamic range of structure-switching sensors can be tuned in order to suit specific applications. Historically this has been performed by reducing or increasing the sensor's affinity via mutations in its binding interface. For example, using this approach, Hellinga and coworkers have pushed the dynamic range of the E. coli maltose and glucose binding proteins up by several orders of magnitude to allow these switches to better suit the measurement of maltose and glucose in beer ($100 mM) [19] and blood serum ($5 mM) [7] , respectively. Unfortunately, this strategy can also alter the specificity of the switch. Optimization of K S , in contrast, provides a ready means of tuning the dynamic range of a switch via alterations at locations distal from the binding site that thus preserve specificity [61] . For example, by comparing the structures of the bound and unbound states of natural switches (Figure 3a) , substitutions distal to the binding site can be identified that specifically stabilize, or destabilize, the binding-competent state [61, 62] . Likewise, the K S of switches made via effector fusions (Figure 3b) can be tuned without impacting specificity by altering the switch-effector interface [63] , or by varying the size of the linker between the two [64] . Finally, switches created by the stabilization of the unfolded state, or another non-binding conformation (Figure 3c,d) , can be optimized by altering the stability of this latter conformation [49 ,55 ] . Thus, this approach to tuning and optimizing the dynamic ranges of switch-based sensors appears quite general.
Conclusion
Biomolecular switches offer a rapid and selective means of transducing binding events into specific output signals in a single step and without the addition of exogenous reagents. Combined with their nanoscale size and their ability to work reversibly and autonomously, structureswitching sensors are therefore well suited for the continuous, real-time monitoring of specific molecules even in environments as complex as the interiors of living cells or blood serum (Figure 1 ). The versatility of biomolecular switches -their ability to be coupled to a range of specific outputs (Figure 2 ), the methods available to engineer switches with widely varying binding specificities (Figure 3) , and the ability to tune their dynamic range (Figure 4 ) -further speaks to their utility. Owing to these attributes, structure-switching sensors have already contributed significantly to biology (see, e.g. the Nobel prize lecture of Tsien [65] ) (also Figure 1a) , and have begun to make inroads in the diagnosis of genetic and infectious diseases (e.g. molecular beacons [8] ). Considering their ability to be readily adapted in a point-of care format (see, e.g. Figure 1b [4 ]), we predict that structure-switching sensors are poised to drive numerous advances in clinical diagnostics [66] , environmental monitoring and industrial process control.
The authors use an Electrochemical Aptamer-based sensor to monitor low micromolar concentrations of cocaine in real-time (approximately 1 min time resolution) in undiluted, unmodified blood serum as it flows through a submicroliter chamber. 
